Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

KNSAKNSA
6 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in KINIKSA PHARMACEUTICALS INTL

Point72 Asset Management, L.P. holds 659,493 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $42.2M as of 2026-Q2. The position was increased (+2.9% shares). KNSA represents 0.0% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$42.2M

Current Shares

659,493

Total Value Change

+$16.6M

Total Shares Change

-489,918

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
659,493
+2.9%
$42.2M0.0%$63.95
30
2026-Q1
Decreased
640,958
-19.6%
$30.9M0.0%$45.37
0
2025-Q4
Increased
797,137
+40.6%
$32.9M0.0%$40.99
38
2025-Q3
Decreased
566,927
-33.2%
$22M0.0%$38.77
0
2025-Q2
Decreased
848,549
-26.2%
$23.5M0.0%$28.04
0
2025-Q1
New
1.1M
-
$25.5M0.1%$23.09
40

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used